Coppell Advisory Solutions’s Clovis Oncology, Inc. CLVS Stock Holding History

Coppell Advisory Solutions's CLVS Position: Q4 2023 in Review

Coppell Advisory Solutions sold out of Clovis Oncology, Inc. (CLVS) in Q4 2023, closing a stake of 229 shares — an estimated $11K sold.

Coppell Advisory Solutions first reported a position in CLVS in Q4 2022 and held it in 2 quarters. The position peaked at $12.7K in Q4 2022. 0 funds tracked by Wall St. Rank hold CLVS as of Q4 2023.

• Coppell Advisory Solutions reported no remaining Clovis Oncology, Inc. position as of Q4 2023 after selling out during the quarter.
• Coppell Advisory Solutions sold 229 Clovis Oncology, Inc. shares in Q4 2023, an estimated $11K.
• Coppell Advisory Solutions first reported a position in Clovis Oncology, Inc. in Q4 2022 and held it in 2 quarters.
• Coppell Advisory Solutions's Clovis Oncology, Inc. position peaked at $12.7K in Q4 2022.
• 0 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2023.

Based on Coppell Advisory Solutions's 13F filing for Q4 2023, filed 14 Feb 2024.